Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
Submitted by
admin
on June 4, 2011 - 10:03am
Source:
Yahoo/BusinessWire
News Tags:
Immunogen
SAR3419
non-Hodgkin's lymphoma
Headline:
ImmunoGen, Inc. Announces Presentation of Favorable SAR3419 Interim Clinical Data at ASCO
Do Not Allow Advertisers to Use My Personal information
